By Joe Cuthbert The recommendations for clinicians from ESC HF Guidelines 2021 most likely to impact management of the heart failure patient: Aim to start…
View More European Society of Cardiology Heart Failure Guidelines 2021: What should we be doing in current practice?Category: BCS Editorials
AF screening and thromboembolic risk: How much AF is significant?
By Andre Briosa e Gala Take Home Messages AF may go undetected in patients until they experience a complication, such as an AF-related stroke. Early…
View More AF screening and thromboembolic risk: How much AF is significant?Exercise as a treatment: do we talk about it enough in Hypertension Management?
By John Graby Take Home Messages CVD remains a leading cause of morbidity and mortality suggesting a need for improving its management Exercise is important…
View More Exercise as a treatment: do we talk about it enough in Hypertension Management?Heart failure with preserved ejection fraction
By Sean Zheng Key messages Heart failure with preserved ejection fraction (HFPEF) is a common cause of hospitalisation, impaired quality of life, restricted functional capacity,…
View More Heart failure with preserved ejection fractionUtility of CT coronary angiography in non-ST elevation acute coronary syndrome
By Syed Ghias Take Home Messages Coronary computed tomographic angiography (CCTA) is a well-established non-invasive diagnostic modality which reliably rules out obstructive coronary artery disease…
View More Utility of CT coronary angiography in non-ST elevation acute coronary syndromeSodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure
By Syed Ghias Take Home Messages Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are a novel class of oral hypoglycaemic medications which have been shown to be effective…
View More Sodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure